Skip to main content

Advertisement

ADVERTISEMENT

News

MiMedx Group

https://clinicaltrials.gov/study/NCT06600724

MiMedx initiated a 170-patient study to evaluate 2 human amnion/chorion membrane (ppLHACM) products, EPIEFFECT and EPIXPRESS and SoC vs SoC alone in the treatment of non-healing DFUs. Primary outcome measures complete healing in 12 wks. Estimated study completion is August 2026. clinicaltrials.gov

Advertisement

Advertisement

Advertisement